Real-time enrollment status for this locally advanced/metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 1:30 PM UTC
| NCT Number | NCT06414460 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced/Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 114 participants |
| Active Locations | 5 sites in the US |
| Sponsor | InSilico Medicine Hong Kong Limited |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of August 30, 2026: Clinical trial NCT06414460 is currently recruiting participants. This phase1 study for locally advanced/metastatic solid tumors is actively seeking new participants at 5 locations across the United States. The study is sponsored by InSilico Medicine Hong Kong Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06414460 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06414460 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.